PD-IDEA: PD-Improved Dialysis Efficiency With Adapted APD

Sponsor
Fresenius Medical Care Deutschland GmbH (Industry)
Overall Status
Completed
CT.gov ID
NCT02470598
Collaborator
(none)
182
50
64
3.6
0.1

Study Details

Study Description

Brief Summary

The aim of this study is to observe the effect of adapted APD (aAPD) on maintenance and/or improvement of the hydration status of more than 250 PD patients, and to observe the tolerability of the therapy over a long period.

Condition or Disease Intervention/Treatment Phase
  • Other: Treatment with Adapted Automated Peritoneal Dialysis (aAPD)

Detailed Description

In some studies it has been observed that the use of a combination of short dwell/small volume and long dwell/large volume can improve the effectiveness of APD. However, these studies have been performed in a small number of patients during a short observation period.

The aim of this study is to assess the hydration status of PD patients treated with aAPD and observe its development during one year using the BCM-Body Composition Monitor (BCM), a bioimpedance spectroscopy (BIS) device. In addition, it is intended to observe the variability of aAPD prescriptions and their influence on the hydration status of the patients.

This is a purely non-interventional, observational study, where treatment decisions are completely guided by the discretion of the attending nephrologists.

Study Design

Study Type:
Observational
Actual Enrollment :
182 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
PD-Improved Dialysis Efficiency With Adapted APD - PD-IDEA
Study Start Date :
Mar 1, 2015
Actual Primary Completion Date :
Jun 30, 2020
Actual Study Completion Date :
Jun 30, 2020

Outcome Measures

Primary Outcome Measures

  1. Hydration status [Every three months during one year]

    Assessed via body composition measurements

Secondary Outcome Measures

  1. Residual renal function [Every three months during one year]

  2. Changes in prescription [Every three months during one year]

  3. Achievement of adequate solute removal [Every three months during one year]

  4. Therapy tolerability [Every three months during one year]

Other Outcome Measures

  1. Change of therapy modality [Every three months during one year]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • CKD patients with indication for renal replacement therapy

  • Patient treated or to be treated with aAPD

  • Fluid status regularly monitored with BCM

Exclusion Criteria:
  • Patients who have any condition prohibiting the use of BCM like patients with major amputations (e.g. lower leg)

  • Participation in an interventional study which could have an effect on the study objectives hydration status and dialysis adequacy (e.g. studies on PD solutions, studies on diuretics)

Contacts and Locations

Locations

Site City State Country Postal Code
1 Faculty Hospital Brno-Bohunice Brno Czechia
2 Hospital Liberec Liberec Czechia
3 Regional Hospital in Mlada Boleslav Mlada Boleslav Czechia
4 Hospital Nove Mesto na Morave Nove Mesto na Morave Czechia
5 Faculty Hospital Pilsen Pilsen Czechia
6 Faculty Hospital Karlovo namesti Prague Czechia
7 Faculty Hospital Strahov Prague Czechia
8 NC centre Vinohrady Prague Czechia
9 NC centre Sokolov Sokolov Czechia
10 Hospital Trebic Trebic Czechia
11 Regional Hospital Viborg Viborg Denmark
12 Helsinki University Hospital Helsinki Finland
13 Kymenlaakso Central Hospital Kotka Finland
14 Regional Hospital Roskilde Lappeenranta Finland
15 Hospital Selayang Batu Caves Malaysia
16 Gleneagles Hospital Kuala Lumpur (GHKL) Kuala Lumpur Malaysia
17 Hospital Universiti Kebangsaan Malaysia (HUKM) Kuala Lumpur Malaysia
18 Hospital Serdang Serdang Malaysia
19 Hospital Seremban Seremban Malaysia
20 Complejo Hospitalario universitario de Albacete Albacete Spain
21 Fundación Hospital de Alcorcón Alcorcón Spain
22 Fundacion Puigvert Barcelona Spain
23 Hospital Clinic de Barcelona Barcelona Spain
24 Hospital de Basurto Bilbao Spain
25 Hospital General de Castellón Castellón De La Plana Spain
26 Hospital Universitario di Girona Josep Trueta Girona Spain
27 Hospital General Virgen de las Nieves Granada Spain
28 Complejo hospitalario de Jaén Jaén Spain
29 Complejo Hospitalario San Millán-San Pedro De La Rioja Logroño Spain
30 Hospital Universitario Lucus Agusti Lugo Spain
31 Hospital Clínico San Carlos Madrid Spain
32 Hospital Universitario Ramón y Cajal Madrid Spain
33 Hospital Universitario Puerta de Hierro Majadahonda Spain
34 Hospital Carlos Haya Málaga Spain
35 Complexo Hospitalario Universitario de Ourense (CHUO) Ourense Spain
36 Hospital Universitario Central de Asturias (HUCA) Oviedo Spain
37 Hospital Universitatio Donostia San Sebastián Spain
38 Complejo Hospital Universitario de Santiago (CHUS) Santiago De Compostela Spain
39 Hospital Clínico de Valencia Valencia Spain
40 Hospital Peset Valencia Spain
41 Hospital Universitari i Politècnic La Fe Valencia Spain
42 Hospital Txagorritxu Vitoria Spain
43 Complejo Asistencial de Avila Ávila Spain
44 Danderyds Sjukhus AB Danderyd Sweden
45 Höglandssjukhuset Eksjö/Nässjö Eksjö Sweden
46 Kalmar Hospital Kalmar Sweden
47 Skåne University Hospital Lund Sweden
48 Länssjukhuset Sundsvall Sundsvall Sweden
49 Norra Älvsborgs Länssjukhus Trollhättan Sweden
50 Norrlands University Hopsital Umeå Sweden

Sponsors and Collaborators

  • Fresenius Medical Care Deutschland GmbH

Investigators

  • Study Director: Michel Fischbach, Prof., University Hospital Hautepierre
  • Study Director: Manel Vera, Dr., Hospital Clinic i Provinvial de Barcelona
  • Study Director: Emilio Galli, Dr., Ospedale "Treviglio-Caravaggio" di Treviglio
  • Study Director: Cecile Courivaud, Dr., University Hospotal Besancon
  • Study Director: Virpi Rauta, Dr., Helsinki Univerity Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Fresenius Medical Care Deutschland GmbH
ClinicalTrials.gov Identifier:
NCT02470598
Other Study ID Numbers:
  • PD-aAPD-01-INT
First Posted:
Jun 12, 2015
Last Update Posted:
Aug 6, 2020
Last Verified:
Jul 1, 2020
Keywords provided by Fresenius Medical Care Deutschland GmbH
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 6, 2020